Best practice

  • HOME
  • ABOUT
  • Best practice

Principles of transparency and best practice of scholarly publishing 4th version

Posted on October 17, 2024

Sixteen check list of compliance of the journal to the Principles of Transparency and Best Practice in Scholarly Publishing version 4.0 published September 15, 2022 (joint statement by Committee on Publication Ethics [COPE], Directory of Open Access Journals [DOAJ], the Open Access Scholarly Publishing Association [OASPA], and the World Association of Medical Editors [WAME]; https://doaj.org/apply/transparency) is as follows:

No. Topics Contents
JOURNAL CONTENT
1 Name of journal The official journal title is Journal of Multiple Sclerosis and Neuroimmunology. https://jmsni.org/about/about.php
2 Website

The URL of the official journal website is https://jmsni.org.

3 Publishing schedule Journal of Multiple Sclerosis and Neuroimmunology is published two times a year (on the last day of June and December).
4 Archiving It is accessible without barrier from Google Scholar (https://scholar.google.com/) in the event a journal is no longer published.
5 Copyright A submitted manuscript, when published, will become the property of the journal. Copyrights of all published materials are owned by Korean Society of Neuroimmunology. https://jmsni.org/authors/authors.php#4
6 Licencing Journal of Multiple Sclerosis and Neuroimmunology is available free in electronic form at https://jmsni.org/index.php. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
JOURNAL PRACTICES
7 Publication ethics and related editorial policies

Journal of Multiple Sclerosis and Neuroimmunology the Guideline on Good Publication of COPE (https://publicationethics.org) and Recommendations of International Committee of Medical Journal Editors (https://www.icmje.org/recommendations).

The Editorial Board of Journal of Multiple Sclerosis and Neuroimmunology carefully examines whether all submitted manuscripts abide the ethical guidelines of ICMJE and COPE. The published articles should include the statements of conflict of interest, author's contribution, Institutional Review Board, informed consent, and human/animal rights.

When the journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by COPE (https://publicationethics.org/resources/flowcharts). The Editorial Board of Journal of Multiple Sclerosis and Neuroimmunology will discuss the suspected cases and reach a decision. Journal of Multiple Sclerosis and Neuroimmunology will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

8 Peer review Journal of Multiple Sclerosis and Neuroimmunology has an online submission and peer review system at https://submit.jmsni.org/.
9 Access Journal of Multiple Sclerosis and Neuroimmunology is an open access journal. A free full-text service, both in XML and PDF formats, is available immediately upon publication without an embargo period.
ORGANIZATION
10 Ownership and management This journal is owned by the publisher, Korean Society of Neuroimmunology.
11 Advisory body The advisory body is the journal's editorial board.
https://jmsni.org/about/editorial.php
12 Editorial team/contact information
BUSINESS PRACTICES
13 Author fees Except in special cases, author fees such as review and publication fees are generally not charged.
14 Other revenue Revenue sources of journal were from the support of publisher (Korean Society of Neuroimmunology). https://jmsni.org/authors/processing_charge.php
15 Advertising https://jmsni.org/policy/advertising.php
16 Direct marketing The Journal of Multiple Sclerosis and Neuroimmunology promotes itself through its website and by distributing an introduction pamphlet. Manuscript submission invitations are typically extended to presenters at conferences, seminars, or workshops that align with the journal's aims and scope.

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972



Editorial Office
Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153   E-mail: icandr@cau.ac.kr                

Copyright © 2024 by Korean Society of Neuroimmunology.

Developed in M2PI